カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腎臓がん治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Kidney Cancer Treatment Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8533 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：71 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Kidney Cancer Treatment Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの腎臓がん治療薬市場規模と予測を収録しています。・世界の腎臓がん治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の腎臓がん治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腎臓がん治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血管新生阻害剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腎臓がん治療薬のグローバル主要企業は、Amgen/Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Pfizer、 Bristol-Myers Squibb、 Eisai、 Prometheus Labs、 Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腎臓がん治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腎臓がん治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の腎臓がん治療薬市場：タイプ別市場シェア、2022年
・血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2）

世界の腎臓がん治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の腎臓がん治療薬市場：用途別市場シェア、2022年
・病院、研究所、診断センター、その他

世界の腎臓がん治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の腎臓がん治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腎臓がん治療薬のグローバル売上、2018年-2023年
・主要企業における腎臓がん治療薬のグローバル売上シェア、2022年
・主要企業における腎臓がん治療薬のグローバル販売量、2018年-2023年
・主要企業における腎臓がん治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen/Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Pfizer、 Bristol-Myers Squibb、 Eisai、 Prometheus Labs、 Novartis

*************************************************************

・調査・分析レポートの概要
腎臓がん治療薬市場の定義
市場セグメント
世界の腎臓がん治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腎臓がん治療薬市場規模
世界の腎臓がん治療薬市場規模：2022年 VS 2029年
世界の腎臓がん治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腎臓がん治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腎臓がん治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫療法（IL-2）
腎臓がん治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究所、診断センター、その他
腎臓がん治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別腎臓がん治療薬市場規模 2022年と2029年
地域別腎臓がん治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen/Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Pfizer、 Bristol-Myers Squibb、 Eisai、 Prometheus Labs、 Novartis
...

Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Treatment Drugs. This report contains market size and forecasts of Kidney Cancer Treatment Drugs in global, including the following market information:
Global Kidney Cancer Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Kidney Cancer Treatment Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Kidney Cancer Treatment Drugs companies in 2022 (%)
The global Kidney Cancer Treatment Drugs market was valued at US$ 5255.3 million in 2022 and is projected to reach US$ 6545.8 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Kidney Cancer Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Kidney Cancer Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Global Kidney Cancer Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Kidney Cancer Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Research Institutes
Diagnostic Centers
Others
Global Kidney Cancer Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Kidney Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer Treatment Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Kidney Cancer Treatment Drugs revenues share in global market, 2022 (%)
Key companies Kidney Cancer Treatment Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Kidney Cancer Treatment Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen/Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Pfizer
Bristol-Myers Squibb
Eisai
Prometheus Labs
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Cancer Treatment Drugs, market overview.
Chapter 2: Global Kidney Cancer Treatment Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Kidney Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Kidney Cancer Treatment Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Treatment Drugs Overall Market Size
2.1 Global Kidney Cancer Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Kidney Cancer Treatment Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Kidney Cancer Treatment Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Kidney Cancer Treatment Drugs Players in Global Market
3.2 Top Global Kidney Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Kidney Cancer Treatment Drugs Revenue by Companies
3.4 Global Kidney Cancer Treatment Drugs Sales by Companies
3.5 Global Kidney Cancer Treatment Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Kidney Cancer Treatment Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Kidney Cancer Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kidney Cancer Treatment Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Kidney Cancer Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Angiogenesis Inhibitors
4.1.3 mTOR Inhibitors
4.1.4 Monoclonal Antibodies
4.1.5 Cytokine Immunotherapy (IL-2)
4.2 By Type – Global Kidney Cancer Treatment Drugs Revenue & Forecasts
4.2.1 By Type – Global Kidney Cancer Treatment Drugs Revenue, 2018-2023
4.2.2 By Type – Global Kidney Cancer Treatment Drugs Revenue, 2024-2029
4.2.3 By Type – Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Kidney Cancer Treatment Drugs Sales & Forecasts
4.3.1 By Type – Global Kidney Cancer Treatment Drugs Sales, 2018-2023
4.3.2 By Type – Global Kidney Cancer Treatment Drugs Sales, 2024-2029
4.3.3 By Type – Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Kidney Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Kidney Cancer Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research Institutes
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application – Global Kidney Cancer Treatment Drugs Revenue & Forecasts
5.2.1 By Application – Global Kidney Cancer Treatment Drugs Revenue, 2018-2023
5.2.2 By Application – Global Kidney Cancer Treatment Drugs Revenue, 2024-2029
5.2.3 By Application – Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Kidney Cancer Treatment Drugs Sales & Forecasts
5.3.1 By Application – Global Kidney Cancer Treatment Drugs Sales, 2018-2023
5.3.2 By Application – Global Kidney Cancer Treatment Drugs Sales, 2024-2029
5.3.3 By Application – Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Kidney Cancer Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Kidney Cancer Treatment Drugs Market Size, 2022 & 2029
6.2 By Region – Global Kidney Cancer Treatment Drugs Revenue & Forecasts
6.2.1 By Region – Global Kidney Cancer Treatment Drugs Revenue, 2018-2023
6.2.2 By Region – Global Kidney Cancer Treatment Drugs Revenue, 2024-2029
6.2.3 By Region – Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Kidney Cancer Treatment Drugs Sales & Forecasts
6.3.1 By Region – Global Kidney Cancer Treatment Drugs Sales, 2018-2023
6.3.2 By Region – Global Kidney Cancer Treatment Drugs Sales, 2024-2029
6.3.3 By Region – Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Kidney Cancer Treatment Drugs Revenue, 2018-2029
6.4.2 By Country – North America Kidney Cancer Treatment Drugs Sales, 2018-2029
6.4.3 US Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.4.4 Canada Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.4.5 Mexico Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Kidney Cancer Treatment Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Kidney Cancer Treatment Drugs Sales, 2018-2029
6.5.3 Germany Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.4 France Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.5 U.K. Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.6 Italy Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.7 Russia Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.5.9 Benelux Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Kidney Cancer Treatment Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Kidney Cancer Treatment Drugs Sales, 2018-2029
6.6.3 China Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.6.4 Japan Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.6.5 South Korea Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.6.7 India Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Kidney Cancer Treatment Drugs Revenue, 2018-2029
6.7.2 By Country – South America Kidney Cancer Treatment Drugs Sales, 2018-2029
6.7.3 Brazil Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.7.4 Argentina Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Kidney Cancer Treatment Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Kidney Cancer Treatment Drugs Sales, 2018-2029
6.8.3 Turkey Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.8.4 Israel Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Kidney Cancer Treatment Drugs Market Size, 2018-2029
6.8.6 UAE Kidney Cancer Treatment Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen/Allergan
7.1.1 Amgen/Allergan Company Summary
7.1.2 Amgen/Allergan Business Overview
7.1.3 Amgen/Allergan Kidney Cancer Treatment Drugs Major Product Offerings
7.1.4 Amgen/Allergan Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen/Allergan Key News & Latest Developments
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Company Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Kidney Cancer Treatment Drugs Major Product Offerings
7.2.4 Argos Therapeutics Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Argos Therapeutics Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Kidney Cancer Treatment Drugs Major Product Offerings
7.3.4 AstraZeneca Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Company Summary
7.4.2 Aveo Pharmaceuticals Business Overview
7.4.3 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Major Product Offerings
7.4.4 Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Aveo Pharmaceuticals Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Kidney Cancer Treatment Drugs Major Product Offerings
7.5.4 Bayer Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Exelixis
7.6.1 Exelixis Company Summary
7.6.2 Exelixis Business Overview
7.6.3 Exelixis Kidney Cancer Treatment Drugs Major Product Offerings
7.6.4 Exelixis Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Exelixis Key News & Latest Developments
7.7 Incyte
7.7.1 Incyte Company Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Kidney Cancer Treatment Drugs Major Product Offerings
7.7.4 Incyte Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Incyte Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Kidney Cancer Treatment Drugs Major Product Offerings
7.8.4 Merck Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Kidney Cancer Treatment Drugs Major Product Offerings
7.9.4 Roche Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Kidney Cancer Treatment Drugs Major Product Offerings
7.10.4 Pfizer Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 Bristol-Myers Squibb
7.11.1 Bristol-Myers Squibb Company Summary
7.11.2 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Business Overview
7.11.3 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Major Product Offerings
7.11.4 Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Bristol-Myers Squibb Key News & Latest Developments
7.12 Eisai
7.12.1 Eisai Company Summary
7.12.2 Eisai Kidney Cancer Treatment Drugs Business Overview
7.12.3 Eisai Kidney Cancer Treatment Drugs Major Product Offerings
7.12.4 Eisai Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Eisai Key News & Latest Developments
7.13 Prometheus Labs
7.13.1 Prometheus Labs Company Summary
7.13.2 Prometheus Labs Kidney Cancer Treatment Drugs Business Overview
7.13.3 Prometheus Labs Kidney Cancer Treatment Drugs Major Product Offerings
7.13.4 Prometheus Labs Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Prometheus Labs Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Kidney Cancer Treatment Drugs Major Product Offerings
7.14.4 Novartis Kidney Cancer Treatment Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Novartis Key News & Latest Developments
8 Global Kidney Cancer Treatment Drugs Production Capacity, Analysis
8.1 Global Kidney Cancer Treatment Drugs Production Capacity, 2018-2029
8.2 Kidney Cancer Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Cancer Treatment Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Cancer Treatment Drugs Supply Chain Analysis
10.1 Kidney Cancer Treatment Drugs Industry Value Chain
10.2 Kidney Cancer Treatment Drugs Upstream Market
10.3 Kidney Cancer Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Cancer Treatment Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Kidney Cancer Treatment Drugs in Global Market
Table 2. Top Kidney Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Kidney Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Kidney Cancer Treatment Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Kidney Cancer Treatment Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Kidney Cancer Treatment Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Kidney Cancer Treatment Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Kidney Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Kidney Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Kidney Cancer Treatment Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Kidney Cancer Treatment Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Kidney Cancer Treatment Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Kidney Cancer Treatment Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Kidney Cancer Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Kidney Cancer Treatment Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Kidney Cancer Treatment Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Kidney Cancer Treatment Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Kidney Cancer Treatment Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Kidney Cancer Treatment Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Kidney Cancer Treatment Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Kidney Cancer Treatment Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Kidney Cancer Treatment Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Kidney Cancer Treatment Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Kidney Cancer Treatment Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales, (K Units), 2024-2029
Table 46. Amgen/Allergan Company Summary
Table 47. Amgen/Allergan Kidney Cancer Treatment Drugs Product Offerings
Table 48. Amgen/Allergan Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen/Allergan Key News & Latest Developments
Table 50. Argos Therapeutics Company Summary
Table 51. Argos Therapeutics Kidney Cancer Treatment Drugs Product Offerings
Table 52. Argos Therapeutics Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Argos Therapeutics Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Kidney Cancer Treatment Drugs Product Offerings
Table 56. AstraZeneca Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Aveo Pharmaceuticals Company Summary
Table 59. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Product Offerings
Table 60. Aveo Pharmaceuticals Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Aveo Pharmaceuticals Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Kidney Cancer Treatment Drugs Product Offerings
Table 64. Bayer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Exelixis Company Summary
Table 67. Exelixis Kidney Cancer Treatment Drugs Product Offerings
Table 68. Exelixis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Exelixis Key News & Latest Developments
Table 70. Incyte Company Summary
Table 71. Incyte Kidney Cancer Treatment Drugs Product Offerings
Table 72. Incyte Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Incyte Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Kidney Cancer Treatment Drugs Product Offerings
Table 76. Merck Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Roche Company Summary
Table 79. Roche Kidney Cancer Treatment Drugs Product Offerings
Table 80. Roche Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Roche Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Kidney Cancer Treatment Drugs Product Offerings
Table 84. Pfizer Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Bristol-Myers Squibb Company Summary
Table 87. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Product Offerings
Table 88. Bristol-Myers Squibb Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Bristol-Myers Squibb Key News & Latest Developments
Table 90. Eisai Company Summary
Table 91. Eisai Kidney Cancer Treatment Drugs Product Offerings
Table 92. Eisai Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Eisai Key News & Latest Developments
Table 94. Prometheus Labs Company Summary
Table 95. Prometheus Labs Kidney Cancer Treatment Drugs Product Offerings
Table 96. Prometheus Labs Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Prometheus Labs Key News & Latest Developments
Table 98. Novartis Company Summary
Table 99. Novartis Kidney Cancer Treatment Drugs Product Offerings
Table 100. Novartis Kidney Cancer Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Novartis Key News & Latest Developments
Table 102. Kidney Cancer Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Kidney Cancer Treatment Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Kidney Cancer Treatment Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Kidney Cancer Treatment Drugs Production by Region, 2024-2029 (K Units)
Table 106. Kidney Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 107. Kidney Cancer Treatment Drugs Market Drivers in Global Market
Table 108. Kidney Cancer Treatment Drugs Market Restraints in Global Market
Table 109. Kidney Cancer Treatment Drugs Raw Materials
Table 110. Kidney Cancer Treatment Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Kidney Cancer Treatment Drugs Downstream
Table 112. Kidney Cancer Treatment Drugs Downstream Clients in Global Market
Table 113. Kidney Cancer Treatment Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Kidney Cancer Treatment Drugs Segment by Type in 2022
Figure 2. Kidney Cancer Treatment Drugs Segment by Application in 2022
Figure 3. Global Kidney Cancer Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney Cancer Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Kidney Cancer Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Kidney Cancer Treatment Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Cancer Treatment Drugs Revenue in 2022
Figure 9. By Type - Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Kidney Cancer Treatment Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Kidney Cancer Treatment Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 23. US Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 28. Germany Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 37. China Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Kidney Cancer Treatment Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Kidney Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Kidney Cancer Treatment Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Kidney Cancer Treatment Drugs by Region, 2022 VS 2029
Figure 54. Kidney Cancer Treatment Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

腎臓がんは、腎臓内で発生する悪性腫瘍の一種であり、その治療にはさまざまな方法と薬剤が用いられています。腎臓がん治療薬に関する概念は多岐にわたりますが、ここではその定義、特徴、種類、用途、関連技術について詳しく述べていきます。

腎臓がん治療薬の定義としては、腎臓に発生した悪性腫瘍、特に腎細胞癌に対して用いられる医薬品を指します。これらの治療薬は、腫瘍の成長を抑制したり、がん細胞を直接攻撃したり、あるいは身体の免疫機能を高めてがんと闘わせることを目的としています。

腎臓がん治療薬にはいくつかの特徴があります。まず第一に、腎臓がんは早期発見が難しいため、多くの場合、進行した段階で診断されることが多いです。このため、治療薬は高度な効果が求められ、高い副作用の管理が不可欠です。また、患者によって腫瘍の特性や進行状況が異なるため、個別化医療が求められています。従って、治療薬の選択肢は多様であり、患者の状態に応じた適切な薬剤が選ばれることが重要です。

腎臓がん治療薬は、主に以下の種類に分類されます。第一に、分子標的薬があります。これらは、がん細胞の成長や血管新生に関与する特定の分子を標的とし、その作用を阻害することで腫瘍の進行を抑制します。代表的な分子標的薬としては、スニチニブ、パゾパニブ、アキシチニブなどがあります。これらの薬剤は、比較的高い効果を示しつつ、副作用も管理しやすいことから、広く使用されています。

次に、免疫チェックポイント阻害剤が挙げられます。これらの薬剤は、免疫系ががん細胞を認識し攻撃するのを助ける働きを持っています。代表的な免疫チェックポイント阻害剤には、ニボルマブやペムブロリズマブがあります。これらは、患者の免疫系を活性化し、がん細胞に対する防御力を高めることで、長期的な効果をもたらすことが期待されます。

さらに、化学療法も腎臓がんの治療に用いられることがありますが、腎臓がんは他のがんに比べて化学療法に対する感受性が低いため、一般的にはあまり選択されません。それでも、一部の患者には効果的な場合もあります。特に、腎臓がんが他の部位への転移を伴っている場合、化学療法が考慮されることがあります。

治療薬の用途としては、主要に根治療法と緩和療法があります。根治療法は、腎臓がんを完全に治癒することを目指すものであり、手術と併用して行われることが多いです。一方、緩和療法は、病気の進行を抑えつつ、患者の生活の質を向上させたり症状を軽減したりすることを目的とします。特に進行がん患者においては、緩和的な治療薬の使用が重要視されています。

関連技術としては、バイオマーカーの開発や新たな治療法の研究が進められています。バイオマーカーとは、がんの特性や治療効果を予測するための指標となる物質のことです。これにより、患者個々の特性に応じた効果的な治療法を選択することが可能になります。また、新薬の開発においては、臨床試験を通じてその有効性や安全性を確認することが不可欠です。このプロセスには、多くのヴァイオテクノロジーやゲノム解析技術が駆使され、より効果の高い治療薬の登場が期待されています。

腎臓がん治療薬の研究と開発は今後も進展することが予測され、多様化する治療選択肢の中から患者に最適な治療法を提供できる体制が整いつつあります。新たな治療法や薬剤の発見により、腎臓がん患者の予後が改善され、より多くの患者が治療の恩恵を受けられることを願っています。今後も、腎臓がんの治療において革新的な進展が続くことを期待しています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腎臓がん治療薬の世界市場見通し2023年-2029年(Kidney Cancer Treatment Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

腎臓がん治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp